Physiomics Plc Cash Flow Conversion Efficiency
Physiomics Plc cash flow conversion efficiency. Based on the latest financial reports, Physiomics Plc (PYC) has a cash flow conversion efficiency ratio of -0.514x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-202.00K ≈ $-24.58 USD) by net assets (GBX393.00K ≈ $47.82 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Physiomics Plc (2001–2025)
Cash flow conversion efficiency of Physiomics Plc from 2001 to 2025. This chart illustrates how Physiomics Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Physiomics Plc (PYC) stock price for real-time trading data and today's change.
Physiomics Plc Cash Flow Conversion Ratio Explained
Physiomics Plc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Physiomics Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Physiomics Plc ranked by their cash flow conversion efficiency. Also see PYC stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Selcuk Gida Endustri Ihracat Ithalat AS
IS:SELGD
|
0.021x |
|
Marwyn Value Investors Ltd
LSE:MVIR
|
0.020x |
|
British and American Investment Trust PLC
LSE:BAF
|
-0.128x |
|
IQ-AI Ltd
LSE:IQAI
|
-0.220x |
|
Platinum Industries Ltd
NSE:PLATIND
|
-0.017x |
|
Cincon Electronics Co Ltd
TWO:3332
|
0.024x |
|
Coral Products
LSE:CRU
|
-0.072x |
|
Premier African Minerals Ltd
LSE:PREM
|
-2.033x |
Annual Cash Flow Conversion Efficiency for Physiomics Plc (2001–2025)
The table below shows the annual cash flow conversion efficiency of Physiomics Plc from 2001 to 2025. Review PYC free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | GBX692.17K ≈ $84.22 |
GBX-546.14K ≈ $-66.45 |
-0.789x | +59.33% |
| 2024-06-30 | GBX282.53K ≈ $34.38 |
GBX-548.13K ≈ $-66.69 |
-1.940x | -289.48% |
| 2023-06-30 | GBX531.72K ≈ $64.69 |
GBX-264.86K ≈ $-32.23 |
-0.498x | -39.03% |
| 2022-06-30 | GBX974.81K ≈ $118.61 |
GBX-349.25K ≈ $-42.49 |
-0.358x | -1185.23% |
| 2021-06-30 | GBX1.17 Million ≈ $141.83 |
GBX-32.50K ≈ $-3.95 |
-0.028x | +68.31% |
| 2020-06-30 | GBX1.31 Million ≈ $160.00 |
GBX-115.69K ≈ $-14.08 |
-0.088x | +62.80% |
| 2019-06-30 | GBX607.91K ≈ $73.97 |
GBX-143.77K ≈ $-17.49 |
-0.237x | +3.89% |
| 2018-06-30 | GBX690.03K ≈ $83.96 |
GBX-169.80K ≈ $-20.66 |
-0.246x | +81.53% |
| 2017-06-30 | GBX328.25K ≈ $39.94 |
GBX-437.27K ≈ $-53.20 |
-1.332x | +21.60% |
| 2016-06-30 | GBX204.15K ≈ $24.84 |
GBX-346.87K ≈ $-42.20 |
-1.699x | -40.90% |
| 2015-06-30 | GBX325.62K ≈ $39.62 |
GBX-392.65K ≈ $-47.77 |
-1.206x | +53.18% |
| 2014-06-30 | GBX136.49K ≈ $16.61 |
GBX-351.51K ≈ $-42.77 |
-2.575x | -25.62% |
| 2013-06-30 | GBX255.82K ≈ $31.13 |
GBX-524.49K ≈ $-63.81 |
-2.050x | -172.94% |
| 2012-06-30 | GBX734.57K ≈ $89.38 |
GBX-551.77K ≈ $-67.13 |
-0.751x | +11.68% |
| 2011-06-30 | GBX756.00K ≈ $91.98 |
GBX-643.00K ≈ $-78.23 |
-0.851x | -54.23% |
| 2010-06-30 | GBX787.00K ≈ $95.76 |
GBX-434.00K ≈ $-52.81 |
-0.551x | -80.29% |
| 2009-06-30 | GBX-85.00K ≈ $-10.34 |
GBX26.00K ≈ $3.16 |
-0.306x | -188.03% |
| 2008-06-30 | GBX-354.00K ≈ $-43.07 |
GBX-123.00K ≈ $-14.97 |
0.347x | +108.89% |
| 2007-06-30 | GBX99.00K ≈ $12.05 |
GBX-387.00K ≈ $-47.09 |
-3.909x | -194.51% |
| 2006-06-30 | GBX-66.00K ≈ $-8.03 |
GBX-273.00K ≈ $-33.22 |
4.136x | +499.14% |
| 2005-06-30 | GBX413.00K ≈ $50.25 |
GBX-428.00K ≈ $-52.08 |
-1.036x | -268.28% |
| 2004-06-30 | GBX-354.00K ≈ $-43.07 |
GBX-218.00K ≈ $-26.52 |
0.616x | -60.87% |
| 2003-06-30 | GBX-129.00K ≈ $-15.70 |
GBX-203.00K ≈ $-24.70 |
1.574x | +233.71% |
| 2001-06-30 | GBX130.00K ≈ $15.82 |
GBX-153.00K ≈ $-18.62 |
-1.177x | -- |
About Physiomics Plc
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour pred… Read more